Search results
Modus Advisors LLC Acquires 450 Shares of AbbVie Inc. (NYSE:ABBV)
ETF DAILY NEWS· 5 days agoModus Advisors LLC raised its holdings in shares of AbbVie Inc. (NYSE:ABBV – Free Report) by 2.0% in the 1st quarter, according to the company in its most recent Form 13F ...
Legacy Financial Strategies LLC Acquires 620 Shares of AbbVie Inc. (NYSE:ABBV)
ETF DAILY NEWS· 2 days agoLegacy Financial Strategies LLC grew its holdings in AbbVie Inc. (NYSE:ABBV – Free Report) by 3.8% in the 1st quarter, according to its most recent disclosure with the Securities ...
AbbVie Inc. (NYSE:ABBV) Shares Bought by Pathway Financial Advisors LLC
ETF DAILY NEWS· 2 days agoPathway Financial Advisors LLC raised its position in AbbVie Inc. (NYSE:ABBV – Free Report) by 3.7% in the 1st quarter, according to its most recent filing with the SEC. The ...
1,533 Shares in AbbVie Inc. (NYSE:ABBV) Acquired by Warren Street Wealth Advisors LLC
ETF DAILY NEWS· 6 days agoWarren Street Wealth Advisors LLC acquired a new position in AbbVie Inc. (NYSE:ABBV – Free Report) in the fourth quarter, according to its most recent 13F filing with the ...
American National Bank Acquires 1,816 Shares of AbbVie Inc. (NYSE:ABBV)
ETF DAILY NEWS· 2 days agoThe institutional investor owned 61,208 shares of the company’s stock after purchasing an additional 1,816 shares during the quarter. AbbVie comprises about ...
AbbVie Inc. (NYSE:ABBV) Shares Sold by Alaska Permanent Fund Corp
ETF DAILY NEWS· 3 days agoThe institutional investor owned 70,497 shares of the company’s stock after selling 1,297 shares during the period. Alaska Permanent Fund Corp’s holdings in AbbVie ...
AbbVie Inc. (NYSE:ABBV) Shares Sold by Capital Market Strategies LLC
ETF DAILY NEWS· 4 days agoCapital Market Strategies LLC cut its stake in AbbVie Inc. (NYSE:ABBV – Free Report) by 4.8% during the 1st quarter, HoldingsChannel reports. The fund owned 10,376 shares ...
AbbVie (NYSE:ABBV) Given New $190.00 Price Target at Piper Sandler
ETF DAILY NEWS· 6 days agoAbbVie (NYSE:ABBV – Get Free Report) had its price objective boosted by research analysts at Piper Sandler from $185.00 to $190.00 in a research note issued on Tuesday, Benzinga ...
AbbVie Inc. (NYSE:ABBV) Shares Sold by Michael S. Ryan Inc.
ETF DAILY NEWS· 5 days agoMichael S. Ryan Inc. lowered its holdings in AbbVie Inc. (NYSE:ABBV – Free Report) by 2.6% in the first quarter, according to its most recent disclosure with the SEC. The ...
AbbVie (NYSE:ABBV) Stock Price Up 1.5% on Analyst Upgrade
ETF DAILY NEWS· 5 days agoAbbVie Inc. (NYSE:ABBV – Get Free Report) shares rose 1.5% during trading on Tuesday after Piper Sandler raised their price target on the stock from $185.00 ...